Scott Summerfield

Having studied for a PhD and post doctoral fellowship in proteomics Scott moved into the field of regulated Bioanalysis in 1997 when joining SmithKline Beecham. In 2001 Scott moved to Neuroscience Drug Discovery to lead a bioanalytical team supporting PK, in vitro DMPK and metabolite ID work. In 2009 he returned to the regulated bioanalytical group, initially as a Section Leader and subsequently as Site Head and currently as WW Head of Bioanalysis at GSK.

Scott has experience of small and molecule bioanalysis as well as leading both bioanalytical and discovery and development project teams across GSK.

What three things would you take if you were stranded on a desert island?

  • A solar powered electric piano
  • A really big crate of whisky
  • A whiskey glass

If you weren’t a bioanalysts what would you be?

  • Author of children’s picture books

What is your favorite city?

  • Paris

Why have you decided to become a Zone Leader?

Good opportunity to contribute more widely to the Bioanalytical Community.

Journal articles from BioanalysisPanel discussions Features
From patient to tube: the importance of physiologically relevant quantitative bioanalytical assays

2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV) (Part 1 – small molecules, peptides and small molecule biomarkers by LCMS)

Issues facing the bioanalytical community: summary of round table discussions

The quest for assay robustness across the life cycle of a bioanalytical method

Integrating internal and external bioanalytical support to deliver a diversified pharmaceutical portfolio

Preliminary investigation into the use of a real-time PCR method for the quantification of an oligonucleotide in human plasma and the development of novel acceptance criteria

The Changing World of Bioanalysis: How do we access the required skillsets?

The Changing World of Bioanalysis: What will the future bioanalytical laboratory look like and what skills will this require?

The Changing World of Bioanalysis: How do we embed science in the Pharma-CRO partnership?

Bioanalysis Zone panel discussion – Part 1: Outsourcing

Bioanalysis Zone panel discussion – Part 2: Pharma and CRO investment

Bioanalysis Zone panel discussion – Part 3: The Skills Gap

An interview with Scott Summerfield: emerging technologies in the bioanalytical field

Ask the Experts – HRMS: where are we now?

An introduction to mass spectrometry with Scott Summerfield

Scott Summerfield: 5 top tips for mass spectrometry